Earnings History Data for YS Biopharma Co., Ltd. (YS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
YS Biopharma Co., Ltd.
YS Biopharma Co. Ltd. is a biopharmaceutical company. It focuses on discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The company operates principally in China, the United States, Singapore, the United Arab Emirates and the Philippines. YS Biopharma Co. Ltd., formerly known as Summit Healthcare Acquisition Corp., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27-07-2023 | PM | YS | YS Biopharma Co., Ltd. | 132.14 | N/A | 0.00 | 0.07 | YS Biopharma GAAP EPS of RMB1.56, revenue of RMB687M [7/27/2023 5:41 AM] |
1.36 | -0.06 (-4.23%) |
1.49 | 0.07 (4.93%) |
1.12 - 18.44 | 136,399 | 110,000 | 31,114 | ||